KRT18 and breast cancer: MDA-MB-231 primary tumors were CK18 positive, EGFR positive, Her2 negative (Figure 1B), demonstrating that the xenograft tumors retained the MDA-MB-231 cell line expression pattern of key breast cancer markers.